For research use only. Not for therapeutic Use.
Betahistine hydrochloride(Cat No.:I004171)is a histamine analog commonly used to treat vertigo and balance disorders, particularly in patients with Meniere’s disease. It works by improving blood flow in the inner ear and stimulating histamine receptors, specifically H1 receptors, which help regulate vascular tone. By enhancing blood circulation to the cochlea and vestibular system, Betahistine can alleviate symptoms like dizziness, ringing in the ears, and hearing loss. It is also thought to reduce the pressure in the inner ear, which may contribute to vestibular dysfunction. Betahistine is typically well-tolerated, with mild side effects like headaches or gastrointestinal discomfort.
Catalog Number | I004171 |
CAS Number | 5579-84-0 (HCl) |
Synonyms | Betahistine dihydrochloride; Betahistine HCl; brand names Veserc, Serc, Hiserk, Betaserc, Vergo.;Methyl[2-(2-pyridyl)ethyl]amine dihydrochloride |
Molecular Formula | C8H14Cl2N2 |
Purity | ≥95% |
Target | H1 receptor agonist |
Solubility | Soluble in DMSO, not in water |
Storage | 0 - 4 °C for short term or -20 °C for long term |
IUPAC Name | N-methyl-2-pyridin-2-ylethanamine;dihydrochloride |
InChI | InChI=1S/C8H12N2.2ClH/c1-9-7-5-8-4-2-3-6-10-8;;/h2-4,6,9H,5,7H2,1H3;2*1H |
InChIKey | XVDFMHARQUBJRE-UHFFFAOYSA-N |
SMILES | CNCCC1=CC=CC=N1.Cl.Cl |